MedCity News June 24, 2021
Direct-to-consumer health startup Hims bought dermatology business Apostrophe. It’s part of a broader push by the company to expand into more indications.
Direct-to-consumer health startup Hims & Hers is buying a dermatology business. The company recently struck a deal to buy Apostrophe, which has a similar business model, for an undisclosed amount.
Oakland, Calif.-based Apostrophe sells prescription acne treatments, such as topical creams and pills. It also offers treatments for wrinkles, rosacea and hair loss.
Like with Hims, users conduct a virtual consultation with a dermatologist, including filling out a questionnaire and sending in images of their skin, before getting a prescription delivered. Apostrophe contracts with an outside physician group for the visits, which cost about $20. The company is...
Today's Sponsors
Today's Sponsor